HCW Biologics’ HCW11-040 prevents bronchopulmonary dysplasia

HCW Biologics Inc.’s HCW11-040 has been shown in IND-enabling studies to prevent bronchopulmonary dysplasia (BPD), a rare pediatric disease affecting underweight premature infants.